ENG/中
老虎证券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由TTMF Limited提供服务
先通医药-B
待上市
成交量:
- -
成交额:
- -
市值:
- -
市盈率:
- -
高:
- -
开:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
5,904.86万
香港流通股本:
5,904.86万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
市销率:
- -
1
开始申购
11/16
2
申购截止
11/19 10:15
3
公布中签
11/20
4
暗盘
11/23 16:15 - 18:30
5
挂牌上市
11/24
总览
公司
新闻资讯
公告
价格范围
52.00 ~ 68.00 HKD
发行价
- -
发行量
656.10万
预计市值
34.12亿 ~ 44.61亿 HKD
最低申购数量
50
承销商
广发融资(香港)有限公司
查看招股说明书
新闻资讯
折价39.2%发行的先通医药-B(09941):稀缺性抢筹、估值倒挂与诊疗一体化的重估博弈
智通财经
·
11/17
“核药第一股”先通医药启动港股招股:茅台、国资入局,亏损压力下闯关18A
蓝鲸财经
·
11/17
新股招股 | 先通医药-B今起招股,一手入场费3434.29港元
老虎资讯综合
·
11/16
“核药第一股”先通医药今起招股,预计11月24日挂牌上市,茅台、国资为股东
独角兽早知道
·
11/16
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hans/stock/09941"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09941","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09941\",,,,,undefined,":{"symbol":"09941","market":"HK","secType":"STK","nameCN":"先通医药-B","latestPrice":0,"timestamp":1795051874169,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":59048600,"shares":59048600,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"11-19 09:31:14","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795483800000},"marketStatusCode":8,"adr":0,"listingDate":1795449600000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1795051800000,1795060800000],[1795064400000,1795075200000]],"volumeRatio":0,"ipoDetail":{"name":"先通医药-B","exchange":"SEHK","listingDate":"2026-11-24","sharesOutstanding":65609614,"sharesFloat":65609614,"offerAmount":6561000,"priceRange":"52.00 - 68.00","market":"HK","openProspectusDate":"2026-11-16","openProspectusUrl":"https://ossnoticepdf.iqdii.com/stockdata/notice/09941/2026/2026111600012_c.pdf","purchaseBeginDate":"2026-11-16","purchaseEndDate":"2026-11-19","winningDate":"2026-11-23","currency":"HKD","minPurchaseQuantity":50,"peRate":-5.83,"use":"1、88.0%(约289.5百万港元)将用于核心产品的研发及注册申报;\n2、4.9%(约16.1百万港元)将用于其他候选产品的研发;\n3、1.1%(约3.5百万港元)将用于加强销售及营销能力;\n4、1.0%(约3.5百万港元)将用于在天津建设新生产基地;\n5、5.0%(约16.5百万港元)将用作营运资金及其他一般企业用途。","industryId":"204005","industryName":"医疗保健","business":"公司致力于开发及商业化具有可观市场潜力的诊断及治疗放射性药物,根据灼识咨询报告,公司是中国首家(i)获得创新放射性药物上市批准的企业;(ii)以MAH身份获得创新放射性药物生产许可的企业;及(iii)完成治疗用放射性配体注册临床试验并获国家药监局受理NDA的企业。","subscribed":2611.74,"marketCap":3411999999.9999995,"minimumCapital":3434.29,"overAllotment":true,"lotSize":50,"issueOpenRate":0.1,"subscribeGear":"50,100,150,200,250,300,350,400,450,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,125000,150000,175000,200000,225000,250000,275000,300000,328050","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-11-23","greyDateTimestamp":1795363200000,"greyOpeningTime":1795421700000,"greyClosingTime":1795429800000,"showGreyQuote":false,"openProspectusDate":"2026-11-16","listingDate":"2026-11-24"},"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09941\",,,,,undefined,":{"symbol":"09941","floatShares":59048600,"roa":"--","roe":"--","lyrEps":0,"shares":59048600,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/09941\",,undefined,":{"id":10911,"type":"COMMON","ipoName":"09941-IPO","symbol":"09941","companyName":"先通医药-B","market":"HK","currency":"HKD","status":"OPEN","underwriter":"广发融资(香港)有限公司","lotSize":50,"minQty":50,"expectedOfferingSize":6561000,"openingDate":1794792600000,"closingDate":1795054500000,"commonClosingDate":1795054500000,"allotmentDate":1795104000000,"listDate":1795449600000,"marginable":true,"marginRate":10,"latestPrice":68,"minPrice":52,"maxPrice":68,"prospectusUrl":"https://ossnoticepdf.iqdii.com/stockdata/notice/09941/2026/2026111600012_c.pdf","allowedQuantities":[50,100,150,200,250,300,350,400,450,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,125000,150000,175000,200000,225000,250000,275000,300000,328050],"interestRate":0,"recommend":false,"isHint":false,"interestStartDate":1795017600000,"interestEndDate":1795017600000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1795421700000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[{"ipoName":"09941-IPO","ipoId":10911,"financingId":64083,"type":1,"availableFundLimit":3434.28,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":34342.8,"maxSubscribeLimit":-1,"marginRate":10,"interestRate":0,"openTime":1794792600000,"closeTime":1795054500000,"isAtValidTime":true,"subscriptionMethod":"FINANCING","processFee":0,"supportPI":false,"applyFundLimit":3434.28,"threshold":50000000000,"isAvailable":false},{"ipoName":"09941-IPO","ipoId":10911,"financingId":64069,"type":4,"availableFundLimit":3434.28,"piAvailableAmountLimit":0,"piMaxAvailableAmountLimit":-1,"piMinSubscribeAmount":0,"piMaxSubscribeAmount":-1,"minSubscribeLimit":0,"maxSubscribeLimit":-1,"marginRate":100,"interestRate":0,"openTime":1794792600000,"closeTime":1795054500000,"isAtValidTime":true,"subscriptionMethod":"CASH","processFee":0,"supportPI":false,"applyFundLimit":3434.28,"threshold":20000000000,"isAvailable":false}],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[{"method":"CASH","closeTime":1795054500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":3434.28},{"method":"FINANCING","closeTime":1795054500000,"available":false,"messageCode":"AVAILABLE_FUND_LIMIT","minAvailableFundLimit":3434.28}],"latestClosingDate":1795054500000,"subscribedFinanceRatio":2611.74,"subscribedRatio":2611.74,"forecastRatio":3421.38,"raiseMoney":44610000,"totalMargin":116522370000,"quoteInfoUpdatedAt":1795051813906,"prospectusUpdatedAt":1794974269000,"forecastMarketValue":3936576840,"minForecastMarketValue":3411699928,"maxForecastMarketValue":4461453752,"sharesOutstanding":65609614,"business":"公司致力于开发及商业化具有可观市场潜力的诊断及治疗放射性药物,根据灼识咨询报告,公司是中国首家(i)获得创新放射性药物上市批准的企业;(ii)以MAH身份获得创新放射性药物生产许可的企业;及(iii)完成治疗用放射性配体注册临床试验并获国家药监局受理NDA的企业。","greyOpeningTime":1795421700000,"greyClosingTime":1795429800000,"tradable":true,"showClawback":true,"clawbackType":"机制B","clawbackRate":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09941\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2684867084","title":"折价39.2%发行的先通医药-B(09941):稀缺性抢筹、估值倒挂与诊疗一体化的重估博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2684867084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684867084?lang=zh_cn&edition=fundamental","pubTime":"2026-11-17 15:55","pubTimestamp":1794902118,"startTime":"0","endTime":"0","summary":"处在招股窗口期的先通医药-B招股热度快速升温。公司本次全球发售656.10万股H股,发售价区间为每股52.00至68.00港元,每手入场费约3434.29港元,预计11月24日挂牌。其一,作为Lutathera的仿制药,XTR008是同类中首个以化药3类提交NDA的候选产品,NDA已获国家药监局受理,预计2026年12月获批,有望成为中国首个靶向SSTR的治疗性放射性配体。更为长远来看,XTR008的核心意义在于推动公司从“诊断型核药企业”向“诊疗一体化平台”重估。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1524303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684672497","title":"“核药第一股”先通医药启动港股招股:茅台、国资入局,亏损压力下闯关18A","url":"https://stock-news.laohu8.com/highlight/detail?id=2684672497","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684672497?lang=zh_cn&edition=fundamental","pubTime":"2026-11-17 15:30","pubTimestamp":1794900623,"startTime":"0","endTime":"0","summary":"若顺利上市,公司将坐实港股“核药第一股”称号。值得注意的是,先通医药IPO前完成至少9轮融资,累计融资超29亿元。先通医药管线覆盖肿瘤、神经退行性疾病、心血管三大领域,共13项资产。2026年12月那张批件,才是“核药第一股”真正的估值开关。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1794898588066257317","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0359202008.SGD","LU0577902371.SGD","LU0072913022.USD","LU0823426308.USD","BK0188","LU0348814723.USD","LU1969619763.USD","LU1226288170.HKD","LU0211977185.USD","LU2177674079.SGD","VXUS","HK0000181112.HKD","LU0501845795.SGD","600519","LU1051768304.USD","LU0588546209.SGD","LU0405327494.USD","LU0594300419.USD","BK0012","BK0183","HK0000181138.USD","IPOS","LU0228659784.USD","SG9999014674.SGD","BK4588","LU1226288253.USD","LU0370786039.SGD","LU0708995583.HKD","LU0823426480.USD","LU0327786744.USD","SG9999001903.USD","BK0215","09941","LU0251143458.SGD","LU1522347837.USD","LU1719994722.HKD","KCAI","IE00BYV24P56.USD","LU0231483743.USD","LU1720050803.USD","LU1226287875.USD","BK0028","LU0048580855.USD","LU1152091754.HKD","LU0516422366.SGD","LU1655091616.SGD","LU1497733631.SGD","LU1146622755.USD","LU0577902538.SGD","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193579181","title":"新股招股 | 先通医药-B今起招股,一手入场费3434.29港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193579181","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193579181?lang=zh_cn&edition=fundamental","pubTime":"2026-11-16 09:25","pubTimestamp":1794792315,"startTime":"0","endTime":"0","summary":"XTR003是目前全球首款且唯一一款18F标记的用于心肌脂肪酸代谢的显像剂,用于检测心肌活力。截至最后实际可行日期,该等产品分别受到12项、13项、15项及1项已授权专利保护。假设超额配股权未获行使及发售价为每股股份60.0港元,公司估计将收取的全球发售所得款项净额约为3.291亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09941"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683665899","title":"“核药第一股”先通医药今起招股,预计11月24日挂牌上市,茅台、国资为股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2683665899","media":"独角兽早知道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683665899?lang=zh_cn&edition=fundamental","pubTime":"2026-11-16 08:11","pubTimestamp":1794787860,"startTime":"0","endTime":"0","summary":"先通医药此次以18A章规则上市,若顺利挂牌,将成为港股“核药第一股”。先通医药当前最具估值弹性的变量,是核心产品XTR008。先通医药的股东名单,在18A公司中属于配置较高、且带有鲜明“产业+国资”色彩的一档。从2005年成立、2016年新三板挂牌、2018年摘牌聚焦核药,到2026年以“核药第一股”的身份启动港股招股,先通医药用二十一年时间在放射性药物这个高壁垒、长周期的赛道里,搭建了一条从回旋加速器到268家医院销售网络的端到端链条。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247615696&idx=1&sn=d59f53c19f4281ee0d98440d10b9460e&chksm=fd8969a93b3c36ce4ef607cb6b888adf67aec79dc310f87b1cdb0bf1b5e826c94507619e8de1&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","09941","BK1574","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}